Paroxetine hydrochloride

盐酸帕罗西汀

Report date: 2025/12/23 11:23:48
NME

Base Information

Drug NameParoxetine hydrochloride
Drug Alias NameParoxetinum帕罗西丁MotivanSeroxatTagonis +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsVasomotor symptomMenopausal symptomsStress Disorders, Post-Traumatic +[16] 
Global Approved IndicationsStress Disorders, Post-TraumaticDepressive DisorderPhobia, Social +[7] 
Approved Indications in ChinaDepression
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1990/01/01
Country/TerritoryCanadaUnited StatesMexico +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesApotex
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcApotexApotex Technologies Inc +[6] 
Inactive CompaniesMylan Pharmaceuticals IncDuke UniversityNew York State Psychiatric Institute +[4] 
Active IndicationsVasomotor symptomMenopausal symptomsStress Disorders, Post-Traumatic +[13] 
Inactive IndicationsDepressive Disorder, MajorAgoraphobiaAnxiety Disorders

Other Information

ATC CodeN06AB05
Related LinksWikipediaDrugBankKEGG